×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Sigachi Industries Limited | 1149.17 | -991.45 | 1109.77 | -2.59 | 1,198 | 15.7 |
| Shukra Pharmaceuticals Limited | NA | NA | NA | NA | 1170 | 116.0 |
| LINCOLN PHARMACEUTICALS LTD. | 1693.38 | 276.75 | 1540.67 | 13.82 | 1102 | 12.8 |
Sigachi Industries Limited, with Security Code 543389, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 76.1 | 77.8 | 79.2 | 76.8 | 83.7 | 80.1 | 109.1 | 105.1 | 113.5 | 111.0 |
| Expenses | 62.1 | 62.6 | 65.9 | 61.0 | 68.7 | 63.7 | 91.1 | 83.9 | 94.8 | 87.0 |
| Operating Profit | 14.0 | 15.2 | 13.3 | 15.8 | 15.0 | 16.4 | 18.0 | 21.2 | 18.8 | 24.0 |
| OPM % | 18.41% | 19.54% | 16.8% | 20.58% | 17.9% | 20.48% | 16.47% | 20.17% | 16.54% | 21.59% |
| Other Income | 1.6 | 1.6 | 1.1 | 1.7 | 7.2 | 1.7 | 14.6 | 2.0 | 1.8 | -117.1 |
| Interest | 1.4 | 1.3 | 1.6 | 1.7 | 2.4 | 2.9 | 1.6 | 3.4 | 2.8 | 2.1 |
| Depreciation | 2.0 | 1.9 | 2.0 | 2.1 | 2.7 | 2.5 | 2.5 | 4.0 | 3.9 | 4.0 |
| Profit before tax | 12.2 | 13.6 | 10.8 | 13.8 | 17.0 | 12.7 | 28.4 | 15.9 | 13.8 | 21.8 |
| Tax % | -22.5% | -25.6% | -22.2% | -21.7% | -31% | -27% | -23.5% | -39.2% | -48.8% | 0.1% |
| Net Profit | 9.4 | 10.1 | 8.4 | 10.8 | 11.7 | 9.3 | 21.7 | 9.7 | 7.0 | -99.1 |
| EPS in Rs | 3.07 | 3.3 | 2.48 | 0.3 | 0.31 | 0.22 | 0.53 | 0.23 | 0 | -2.59 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 68.8 | 72.4 | 84.7 | 99.2 | 111.0 | 104.1 | 95.7 | 124.9 | 139.4 | 128.2 |
| Expenses | 54.8 | 60.2 | 68.4 | 77.8 | 88.4 | 87.8 | 74.7 | 107.7 | 106.2 | 99.6 |
| Operating Profit | 14.0 | 12.2 | 16.3 | 21.4 | 22.6 | 16.3 | 21.0 | 17.2 | 33.2 | 28.6 |
| OPM % | 20.35% | 16.81% | 19.26% | 21.6% | 20.36% | 15.68% | 21.97% | 13.79% | 23.8% | 22.29% |
| Other Income | 1.3 | 1.6 | 1.6 | 1.1 | 1.7 | 7.2 | 1.7 | 14.6 | 2.0 | 2.2 |
| Interest | 1.2 | 1.4 | 1.3 | 1.8 | 1.8 | 2.9 | 3.2 | 2.1 | 3.8 | 3.3 |
| Depreciation | 1.8 | 2.0 | 2.0 | 2.5 | 2.8 | 3.5 | 3.1 | 3.2 | 4.7 | 4.7 |
| Profit before tax | 12.3 | 10.3 | 14.7 | 18.2 | 19.6 | 17.2 | 16.4 | 26.5 | 26.7 | 22.7 |
| Tax % | -20.3% | -29.2% | -26% | -17% | -18% | -11.9% | -22.2% | -20.8% | -23.2% | -28.2% |
| Net Profit | 9.8 | 7.3 | 10.9 | 15.1 | 16.1 | 15.2 | 12.8 | 21.0 | 20.5 | 16.2 |
| EPS in Rs | 3.2 | 2.38 | 3.54 | 4.48 | 0.43 | 0.41 | 0.32 | 0.53 | 0.52 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 16% |
| 3 Years: | 12% |
| TTM: | 35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 18% |
| 1 Year: | -39% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | 27% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | 24% |
| TTM: | 40% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 18% |
| 1 Year: | -39% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|